Sertraline induced severe neutropenia: An adolescent case with the Guillain-Barre Syndrome

Creative Commons License

Akcay E., YALÇIN Ö.

KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY, vol.24, no.3, pp.413-415, 2021 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.5505/kpd.2021.42650
  • Journal Name: KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, Psycinfo, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.413-415
  • Keywords: Neutropenia, Agranulocytosis, Sertraline, Antidepressants, Drug-Related Side Effects and Adverse Reactions
  • Ankara University Affiliated: Yes

Abstract

Neutropenia, which is defined as a neutrophil count below 1500/ml, is a rare but potentially life-threatening side effect of psychotropic drugs. Neutropenia associated with sertraline, which is a selective serotonin reuptake inhibitor (SSRI) antidepressant, has been reported in only five case reports so far. We report a 16-year-old adolescent male diagnosed with Guillain-Barre Syndrome who developed severe neutropenia during treatment with sertraline for his depressive and anxious symptoms.